Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-19-006144
Date:2019-12-13
Issuer: PROGENICS PHARMACEUTICALS INC (PGNX)
Original Submission Date:

Reporting Person:

BER GERARD
UNTERE ROOSTMATT 16
CH 6300, V8 V8

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 5.01 2019-12-13 deemed execution date A 16,393 (a) 2019-12-13 2029-12-13 common stock 16,393 $5.01 16,393 direct
Footnotes
IDfootnote
f1 this stock option becomes exercisable immediately on the date of grant.
WhaleWisdom Logo

Elevate your investments